Institute of Fundamental Technological Research
Polish Academy of Sciences

Partners

Paweł Żebrowski


Recent publications
1.  Golenia A., Olejnik P., Grusiecka-Stańczyk M., Żołek N.S., Wojtaszek E., Żebrowski P., Raszeja-Wyszomirska J., Jolanta M., Cognitive impairment in patients awaiting kidney and liver transplantation—A clinically relevant problem?, Brain and Behavior, ISSN: 2162-3279, DOI: 10.1002/brb3.3647, Vol.14, No.8, pp.1-10, 2024

Abstract:
Introduction: Cognitive impairment (CI) is common in both end-stage kidney disease (ESKD) and alcohol-related liver cirrhosis. The aim of this study was to assess the prevalence and patterns of CI in patients awaiting kidney and liver transplantation, and to identify its determinants.

Methods: In this cross-sectional, prospective study, 31 consecutive patients with ESKD and 31 consecutive patients with alcohol-related liver cirrhosis, all currently on transplant waiting lists, were screened for cognitive decline using the Addenbrooke's Cognitive Examination. Medical history, demographics, and laboratory test results were also collected.

Results: The prevalence of CI among patients with ESKD and alcohol-related liver cirrhosis was 26% and 90%, respectively. In both groups, memory was the most affected cognitive domain, along with verbal fluency in patients with ESKD, and visuospatial abilities in patients with alcoholic cirrhosis. The most statistically significant increase in the prevalence of CI was found in patients with lower educational attainment, in both alcohol-related liver cirrhosis and ESKD populations as well as in older patients with alcoholic cirrhosis. Furthermore, better cognitive functioning in ESKD patients was associated with higher levels of total lymphocyte count and alanine transaminase (ALT), and in alcohol-related liver cirrhosis patients with higher levels of ALT and aspartate transaminase. A nonsignificant trend toward lower memory domain scores was also observed with increasing ammonia levels and increasing severity of liver disease (higher Child-Pugh scores). Finally, suboptimal performance on the screening test was correlated with the severity of liver disease as assessed by the Model for End-Stage Liver Disease Sodium (MELD-Na), but not at the statistically significant level.

Conclusions: The prevalence of CI, especially in patients with alcohol-related liver cirrhosis, is high and can be a significant clinical problem, negatively affecting the transplantation process. Routine screening tests in this group would contribute to the implementation of appropriate management, such as rehabilitation program or psychosocial treatments and facilitate the provision of specialized health care.

Keywords:
cognitive impairment, end‐stage kidney disease, end‐stage liver disease

Affiliations:
Golenia A. - other affiliation
Olejnik P. - other affiliation
Grusiecka-Stańczyk M. - other affiliation
Żołek N.S. - IPPT PAN
Wojtaszek E. - other affiliation
Żebrowski P. - other affiliation
Raszeja-Wyszomirska J. - other affiliation
Jolanta M. - other affiliation
2.  Golenia A., Żołek N., Olejnik P., Żebrowski P., Małyszko J., Patterns of Cognitive Impairment in Hemodialysis Patients and Related Factors including Depression and Anxiety, Journal of Clinical Medicine, ISSN: 2077-0383, DOI: 10.3390/jcm12093119, Vol.12, No.9, pp.3119-3119, 2023

Abstract:
Introduction: Hemodialysis patients are at higher risk of developing cognitive impairment, but the pattern of affected cognitive domains is still undetermined. Little is also known about the symptoms of depression and anxiety in hemodialysis patients. Methods: In this cross-sectional study, we included 74 consecutive adult patients undergoing hemodialysis. Cognitive functions were assessed using the Addenbrooke Cognitive Test III. In addition, all patients were screened for symptoms of depression and anxiety using the Hospital Anxiety and Depression Scale. Results: The mean age of hemodialysis patients was 65.69 ± 14 years. Among the patients, there were 27% and 31% of patients with mild cognitive impairment and suspected dementia, respectively. In the group of patients with suspected dementia, all cognitive functions had significantly lower values compared to these functions in incognitively unimpaired and mild cognitive impairment patients. The most impaired domain was verbal fluency, which reflects impairments in executive function. Depression and anxiety symptoms were observed in 28% and 22% of patients, respectively. Patients with anxiety symptoms had higher levels of endogenous creatinine, parathyroid hormone, and hemoglobin, as well as decreased creatinine clearance, being younger and less educated. No factors contributing to the occurrence of depressive symptoms were found. Conclusion: Cognitive dysfunction is a significant problem in hemodialysis patients. Our study showed that the prevalence of cognitive impairment and depression and anxiety symptoms in hemodialysis patients was high. The domain of executive functions was most affected. Furthermore, creatinine, parathyroid hormone, hemoglobin levels, creatinine clearance, and education affected the anxiety scale score.

Keywords:
hemodialysis,cognitive impairment,depression,anxiety

Affiliations:
Golenia A. - other affiliation
Żołek N. - IPPT PAN
Olejnik P. - other affiliation
Żebrowski P. - other affiliation
Małyszko J. - other affiliation

Category A Plus

IPPT PAN

logo ippt            Pawińskiego 5B, 02-106 Warsaw
  +48 22 826 12 81 (central)
  +48 22 826 98 15
 

Find Us

mapka
© Institute of Fundamental Technological Research Polish Academy of Sciences 2024